AAAAAA

   
Results: 1-7 |
Results: 7
Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Authors: Grimm, RH Margolis, KL Papademetriou, V Cushman, WC Ford, CE Bettencourt, J Alderman, MH Basile, JN Black, HR DeQuattro, V Eckfeldt, J Hawkins, CM Perry, HM Proschan, M
Citation: Rh. Grimm et al., Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT), HYPERTENSIO, 37(1), 2001, pp. 19-27
A genome scan for renal function among hypertensives: The HyperGEN study
Authors: DeWan, AT Arnett, DK Atwood, LD Province, MA Lewis, CE Hunt, SC Eckfeldt, J
Citation: At. Dewan et al., A genome scan for renal function among hypertensives: The HyperGEN study, AM J HU GEN, 68(1), 2001, pp. 136-144
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone - The Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial (ALLHAT)
Authors: Furberg, CD Wright, JT Davis, BR Cutler, JA Alderman, M Black, H Cushman, W Grimm, R Haywood, LJ Leenen, F Oparil, S Perry, HM Probstfield, J Whelton, P Payne, G Nwachuku, C Gordon, D Proschan, M Frommer, P Einhorn, P Hawkins, M Ford, C Pressel, S Piller, L Lusk, C Bettencourt, J Kimmel, B Geraci, T Walsh, S Rahman, M Juratovac, A Pospisil, R Brennan, K Carroll, L Sullivan, S Barone, G Christian, R Feldman, S Lucente, T Lewis, CE Jenkins, K McDowell, P Johnson, J Kingry, C Letterer, R Margolis, K Holland, L Jaeger-Fox, B Williamson, J Louis, G Ragusa, P Williard, A Ferguson, RS Tanner, J Eckfeldt, J Crow, R Pelosi, J
Citation: Cd. Furberg et al., Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone - The Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial (ALLHAT), J AM MED A, 283(15), 2000, pp. 1967-1975
Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study
Authors: Muntner, P Coresh, J Smith, JC Eckfeldt, J Klag, MJ
Citation: P. Muntner et al., Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities Study, KIDNEY INT, 58(1), 2000, pp. 293-301
No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index: The National Heart, Lung, and Blood Institute Family Heart Study
Authors: Hong, YL Leppert, MF Lin, J Hunt, SC Rich, SS Arnett, DK Myers, RH Eckfeldt, J Williams, RR Province, MA
Citation: Yl. Hong et al., No evidence of linkage between the very-low-density lipoprotein receptor gene and fasting serum insulin or homeostasis model assessment insulin resistance index: The National Heart, Lung, and Blood Institute Family Heart Study, METABOLISM, 49(3), 2000, pp. 293-297
Serum albumin level as a predictor of incident coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) study
Authors: Nelson, JJ Liao, DP Sharrett, AR Folsom, AR Chambless, LE Shahar, E Szklo, M Eckfeldt, J Heiss, G
Citation: Jj. Nelson et al., Serum albumin level as a predictor of incident coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) study, AM J EPIDEM, 151(5), 2000, pp. 468-477
Lewis blood group phenotype as an independent risk factor for coronary heart disease (The NHLBI Family Heart Study)
Authors: Ellison, RC Zhang, YQ Myers, RH Swanson, JL Higgins, M Eckfeldt, J
Citation: Rc. Ellison et al., Lewis blood group phenotype as an independent risk factor for coronary heart disease (The NHLBI Family Heart Study), AM J CARD, 83(3), 1999, pp. 345-348
Risultati: 1-7 |